Bayer AG - Stockholders' Newsletter Second Quarter 2007 - Statements of Recognized Income and Expense

4 of 8

Financial Statements

Bayer Group Consolidated Statements of Recognized Income and Expense

	2nd Quarter 2006	2nd Quarter 2007	1st Half 2006	1st. Half 2007
€ million
Changes in fair values of derivatives designated as hedges and available-for-sale financial assets, recognized in stockholders’ equity	(21)	(3)	(12)	(2)
Changes in actuarial gains/losses on defined benefit obligations for pensions and other post-employment benefits, recognized in stockholders’ equity	382	774	1,187	1,105
Exchange differences on translation of operations outside the euro zone, recognized in stockholders’ equity	(331)	(36)	(475)	7
Deferred taxes on valuation adjustments offset directly against stockholders’ equity	(146)	(297)	(461)	(431)
Changes due to changes in scope of consolidation	-	5	-	36
Valuation adjustments recognized directly in stockholders’ equity	(116)	443	239	715
Minority interests in partnerships, recognized in stockholders’ equity	-	(12)	-	(19)
Income after taxes	455	657	1,052	3,467
Total income and expense recognized in the financial statements	339	1,088	1,291	4,163
of which attributable to minority interest	2	(4)	(3)	(2)
of which attributable to Bayer AG stockholders	337	1,092	1,294	4,165